Lance Cowey
0000-0002-9726-5309
2 papers found
Refreshing results…
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238
Challenging the standard of care in advanced melanoma: focus on pembrolizumab
Missing publications? Search for publications with a matching author name.